financetom
Business
financetom
/
Business
/
Bumble Q4 Swings to Losses, Revenue Declines; Q1 Guidance Set
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bumble Q4 Swings to Losses, Revenue Declines; Q1 Guidance Set
Mar 11, 2026 1:49 PM

04:23 PM EDT, 03/11/2026 (MT Newswires) -- Bumble (BMBL) reported a Q4 loss late Wednesday of $4.06, swinging from earnings of $0.04 a year earlier.

Analysts surveyed by FactSet expected earnings of $0.23.

Revenue for the three months ended Dec. 31 was $224.2 million, down from $261.6 million a year earlier.

Analysts polled by FactSet expected $221.4 million.

For Q1, the company expects revenue of $209 million to $213 million.

Analysts expect $211 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Glencore plans to shut Canada's largest copper metal operation over costs, sources say
Glencore plans to shut Canada's largest copper metal operation over costs, sources say
Nov 4, 2025
(Refiles NOV 3 story to add attribution to headline, no change to story text) By Pratima Desai LONDON (Reuters) -Glencore ( GLCNF ) is planning to close its Horne smelter, Canada's largest copper metal-producing operation, due to environmental issues and the millions of dollars needed to upgrade the facility, two sources with knowledge of the matter said. The London-listed miner...
Evoke Pharma Enters into Definitive Agreement to Be Acquired by QOL Medical
Evoke Pharma Enters into Definitive Agreement to Be Acquired by QOL Medical
Nov 4, 2025
QOL Medical to Acquire All Outstanding Shares of Evoke for $11.00 Per Share in Cash Represents a 139.7% premium to most recent Nasdaq closing price Transaction expected to close by the end of 2025 SOLANA BEACH, Calif., and VERO BEACH, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. ( EVOK ) (“Evoke”), a specialty pharmaceutical company focused primarily...
Stanley Black & Decker posts Q3 revenue in line with estimates, cuts forecast
Stanley Black & Decker posts Q3 revenue in line with estimates, cuts forecast
Nov 4, 2025
Overview * Stanley Black & Decker ( SWK ) Q3 revenue of $3.756 bln, in line with analyst expectations * Adjusted EPS for Q3 beats consensus, aided by tax rate benefit * Company reports gross margin expansion due to pricing strategies and supply chain efficiencies Outlook * Stanley Black & Decker ( SWK ) revises 2025 GAAP EPS to $2.55-$2.70...
Propanc Biopharma, Inc. Pursues Strategic Acquisition Plan Targeting Digital Asset Treasury (DAT) Companies Trading Below Market Cap to Net Asset Value (MNAV)
Propanc Biopharma, Inc. Pursues Strategic Acquisition Plan Targeting Digital Asset Treasury (DAT) Companies Trading Below Market Cap to Net Asset Value (MNAV)
Nov 4, 2025
MELBOURNE, Australia, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. ( PPCB ) (“Propanc” or the “Company”), a biopharmaceutical company developing new treatments for patients suffering from recurrent and metastatic cancer, today announced a strategic initiative to pursue the acquisition of Digital Asset Treasury (DAT) companies that are currently trading below their Market Cap to Net Asset Value (MNAV)....
Copyright 2023-2026 - www.financetom.com All Rights Reserved